GOODBADAND IN BETWEEN: NEW LITERATURE HIGHLIGHTS Top Article of 2019 - - PDF document

I-1635547.1 Willcox Savage

GOOD…BAD…AND IN BETWEEN: NEW LITERATURE HIGHLIGHTS Top Article of 2019 Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐ Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, “Mesothelioma: Scientific clues for prevention, diagnosis, and therapy,” CA: A Cancer Journal For Clinicians, 2019 Sep 1;(69(5):402-429 Non-Asbestos Related Meso Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL, “Malignant mesothelioma and its non-asbestos causes,” Archives of Pathology & Laboratory Medicine, 2018 Feb 26;142(6):753-60. *Finkelstein MM. “Malignant Mesothelioma and Its Nonasbestos Causes,” Archives of Pathology & Laboratory Medicine, 2019 Jun;143(6):659. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. In Reply to “Malignant Mesothelioma and Its Nonasbestos Causes”, Archives of Pathology & Laboratory Medicine. 2019 Aug;143(8):911-4. Fiber Potency Korchevskiy A, Rasmuson JO, Rasmuson EJ. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality. Inhalation

• Toxicology. 2019 Apr 16;31(5):180-91

Localized Mesothelioma Marchevsky AM, Khoor A, Walts AE, Nicholson AG, Zhang YZ, Roggli V, Carney J, Roden AC, Tazelaar HD, Larsen BT, LeStang N, “Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel,” Modern Pathology,” 2019 Sep 4:1-6. Hung YP, Dong F, Dubuc AM, Dal Cin P, Bueno R, Chirieac LR, “Molecular characterization of localized pleural mesothelioma,” Modern Pathology. 2019 Aug 1:1-0

2

I-1635547.1 Willcox Savage

New Literature Highlights – 2019 Reading List Genetic Predisposition to Cancer/Mesothelioma

• Hassan R, Morrow B, Thomas A, Walsh T, Lee MK, Gulsuner S, Gadiraju M, Panou V,

Gao S, Mian I, Khan J, “Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy,” Proceedings of the National Academy of

• Sciences. 2019 Apr 30;116(18):9008-13 (Commentary)
• Martincorena I, “Somatic mutation and clonal expansions in human tissues, Genome

Medicine, 2019 Dec;11(1):35 (Commentary)

• Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek

A, Nash GM, Shoushtari A, Chapman P, D’Angelo S., “Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations,” Journal of Thoracic Oncology, 2019 Jul 16; 14(11):189-1994

• Yizhak K, Aguet F, Kim J, Hess JM, Kübler K, Grimsby J, Frazer R, Zhang H,

Haradhvala NJ, Rosebrock D, Livitz D, “RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues,” Science, 2019 Jun 7;364(6444):eaaw0726

• Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R,

Felley‐Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, “Mesothelioma: Scientific clues for prevention, diagnosis, and therapy,” CA: A Cancer Journal For Clinicians, 2019 Sep 1;(69(5):402-429

• Tomasetti C., “Mutated clones are the new normal”, Science. 2019 Jun 7;364(6444):938-

9

• Kennedy SR, Zhang Y, Risques RA., “Cancer-Associated Mutations but No Cancer:

Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection,” Trends in Cancer. 2019 Sep;5(9):531-540

• Levpuscek, “The influence of genetic variability of DNA repair mechanisms on the risk
• f malignant mesothelioma,” Radiol Oncol 2019; 53(2): 206-212
• Coco S, Bonfiglio S, Cittaro D, Vanni I, Mora M, Genova C, Dal Bello MG, Boccardo S,

Alama A, Rijavec E, Sini C, “Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers, 2019 Apr;11(4):441.

• Betti M, Aspesi A, Sculco M, Matullo G, Magnani C, Dianzani I., “Genetic

predisposition for malignant mesothelioma: a concise review,” Mutation Research/Reviews in Mutation Research, 2019 Mar 6

3

I-1635547.1 Willcox Savage

Nanotubes/Asbestos/Inflammation Dong J, Ma Q. “Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes,”

• Nanotoxicology. 2019 Oct 21;13(9):1244-74

Emerce E, Ghosh M, Ỏner D, Duca RC, Vanoirbeek J, Bekaert B, Hoet PH, Godderis L., “Carbon Nanotube-and Asbestos-Induced DNA and RNA Methylation Changes in Bronchial Epithelial Cells,” Chemical Research in Toxicology, 2019 May 1 Talc Marsh GM, Ierardi AM, Benson SM, Finley BL. “Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration

• f latency period,” Inhalation Toxicology. 2019 May 12;31(6):213-23

Fordyce TA, Leonhard M, Mowat FS, Moolgavkar SH, “A 37-year Update on Mortality Patterns in an Expanded Cohort of Vermont Talc Miners and Millers,” Journal of Occupational And Environmental Medicine. 2019 Nov;61(11):916-923 Taher MK, Farhat N, Karyakina NA, Shilnikova N, Ramoju S, Gravel CA, Krishnan K, Mattison D, Wen SW, Krewski D., “Critical Review of the Association between Perineal Use of Talc Powder and Risk of Ovarian Cancer,” Reproductive Toxicology, 2019 Aug 28;90:88-101 McDonald SA, Fan Y, Welch WR, Cramer DW, Godleski JJ, “Migration of Talc From the Perineum to Multiple Pelvic Organ Sites: Five Case Studies With Correlative Light and Scanning Electron Microscopy,” American Journal of Clinical Pathology, 2019 Jul 15;152(5):590-607 O’Brien KM, D’Aloisio AA, Shi M, Murphy JD, Sandler DP, Weinberg CR, “Perineal Talc Use, Douching, and the Risk of Uterine Cancer,” Epidemiology, 2019 Nov 1;30(6):845-52 Rasmussen PE, Levevsque C, Niu, J, Gardner., “Characterization of airborne Particles Emitted During application of Cosmetic Talc Products,” Int J Environ Res Public Health, 2019, 16, 3830 Tran TH, Steffen JE, Clancy KM, Bird T, Egilman DS, “Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance,” Epidemiology. 2019 Nov 1;30(6):783-8 Gabriel IM, Vitonis AF, Welch WR, Titus L, Cramer DW., “Douching, talc use, and risk for

• varian cancer and conditions related to genital tract inflammation,” Cancer Epidemiology and

Prevention Biomarkers. 2019 Nov 1;28(11):1835-44 Rosner, et al., “Nondetected: The Politics of Measurement of Asbestos in Talc, 1971–1976,” AJPH July 2019, Vol 109, No. Rosner D, Markowitz G, Chowkwanyun M. “Nondetected”: The Politics of Measurement of Asbestos in Talc, 1971–1976,” American Journal of Public Health. 2019 Jul;109(7):969-77

4

I-1635547.1 Willcox Savage

Idiopathic Interstitial Fibrosis & Lung Cancer Whittaker Brown SA, Dobelle M, Padilla M, Agovino M, Wisnivesky JP, Hashim D, Boffetta P. “Idiopathic Pulmonary Fibrosis and Lung Cancer: A Systematic Review and Meta-Analysis,” Annals of the American Thoracic Society, 2019 Aug;16(8):1041-1051 Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. International Journal of Molecular Sciences. 2019 Jan;20(3):593 Friction Products Poland CA, Duffin R, “The toxicology of chrysotile-containing brake debris: implications for mesothelioma,” Critical Reviews in Toxicology, 2019 Jan 2;49(1):11-35. Risk of Meso after Cessation of Exposure Boffetta P, Donato F, Pira E, Luu HN, La Vecchia C, “Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression,” International Archives of Occupational and Environmental Health, 2019 Oct;92(7):949-957 Fiber Burden Roggli VL, Green CL., “Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragments,” Ultrastructural Pathology, 2019 Jan 2;43(1):1-5 WDPM Kim M, Kim HS, “Clinicopathological Characteristics of Well-differentiated Papillary Mesothelioma of The Peritoneum: A Single-institutional Experience of 12 Cases. In Vivo, 2019 Mar 1;33(2):633-42 Sun, Hongbing, “North-south gradient of mesothelioma and asbestos consumption-production in the United States-Progresses since the 1st asbestos partial ban in 1973,” Am J Ind Med, 2019;62:337-346 Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin, “Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry,” Annals of Surgical Oncology, 2019 Mar 15;26(3):852-60

5

I-1635547.1 Willcox Savage

Diagnosis of Mesothelioma Le Stang, N., Burke, L., Blaizot, G., Gibbs, A.R., Lebailly, P., Clin, B., Girard, N., Galateau- Sallé, F. and MESOPATH and EURACAN networks, 2019, “Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies - A New Proposal That May Influence Pathologic Practice,” Archives of Pathology & Laboratory Medicine, 2019 Aug 7 Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐ Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, “Mesothelioma: Scientific clues for prevention, diagnosis, and therapy,” CA: A Cancer Journal For Clinicians, 2019 Sep 1;69(5):402-429 Percentage of Mesothelioma Patients With Asbestos Exposure History Letica-Kriegel AS, Leinwand JC, Sonett JR, Gorenstein LA, Taub RN, Chabot JA, Kluger MD, “50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single- Institution Experience,” Annals of Surgical Oncology. 2019 May 7:1-9 Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐ Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, “Mesothelioma: Scientific clues for prevention, diagnosis, and therapy,” CA: A Cancer Journal For Clinicians, 2019 Sep 1;69(5):402-429 Salo SA, Ilonen I, Laaksonen S, Myllärniemi M, Salo JA, Rantanen T, “Malignant Peritoneal Mesothelioma: Treatment Options and Survival,” Anticancer Research, 2019 Feb 1;39(2):839-45 Rojas L, Cardona AF, Trejo‐Rosales R, Zatarain‐Barrón ZL, Ramírez‐Tirado LA, Ruiz‐Patiño A, Campos Gómez S, Corrales L, Oblitas G, Bacon L, Martín C, “Characteristics and long‐term

• utcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP),” Thoracic

Cancer, 2019 Mar;10(3):508-18 Colorectal Cancer and Asbestos Exposure Huang Q, Lan Yj, “Colorectal cancer and asbestos exposure—an overview,” Industrial Health, 2019 Sep 12:2018-0271

6

I-1635547.1 Willcox Savage

Peritoneal Mesothelioma Luberto F, Ferrante D, Silvestri S, Angelini A, Cuccaro F, Nannavecchia AM, Oddone E, Vicentini M, Barone-Adesi F, Cena T, Mirabelli D, “Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy,” Environmental Health, 2019 Dec 1;18(1):71. Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐ Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, “Mesothelioma: Scientific clues for prevention, diagnosis, and therapy,” CA: A Cancer Journal for Clinicians, 2019 Sep 1;69(5):402-429. Salo SA, Ilonen I, Laaksonen S, Myllärniemi M, Salo JA, Rantanen T, “Malignant Peritoneal Mesothelioma: Treatment Options and Survival,” Anticancer Research, 2019 Feb 1;39(2):839- 45. Cashin PH, Jansson Palmer G, Asplund D, Graf W, Syk I, “Peritoneal mesothelioma in Sweden: A population‐based study,” Cancer Medicine, 2019 Oct;8(14):6468-75. Consonni D, Calvi C, De Matteis S, Mirabelli D, Landi MT, Caporaso NE, Peters S, Vermeulen R, Kromhout H, Dallari B, Pesatori AC, “Peritoneal mesothelioma and asbestos exposure: a population-based case–control study in Lombardy, Italy,” Occupational and Environmental Medicine, 2019 Aug 1;76(8):545-53 Lung Cancer/Smoking Attributable Mortality Lariscy JT, “Smoking-attributable mortality by cause of death in the United States: An indirect approach,” SSM-Population Health,” 2019 Apr 1;7:100349 Cardona AF, Rojas L, Zatarain-Barrón ZL, Ruiz-Patiño A, Ricaurte L, Corrales L, Martin C, Freitas H, Cordeiro de Lima VC, Rodriguez J, Avila J, “Multigene mutation profiling and clinical characteristics of small-cell lung cancer in never-smokers versus heavy smokers (Geno1. 3-CLICaP∫),” Frontiers in Oncology, 2019;9:254. Environmental Exposure/Mesothelioma Dalsgaard SB, Würtz ET, Hansen J, Røe OD, Omland Ø, “Environmental asbestos exposure in childhood and risk of mesothelioma later in life: a long-term follow-up register-based cohort study,” Occupational and Environmental Medicine, 2019 Jun 1;76(6):407-13.